Prevalence and comorbidity of nocturnal wandering in the US adult general population

摘要: Objective: To assess the prevalence and comorbid conditions of nocturnal wandering with abnormal state consciousness (NW) in American general population. Methods: Cross-sectional study conducted a representative sample 19,136 noninstitutionalized individuals US population ≥18 years old. The Sleep-EVAL expert system administered questions on life sleeping habits; health; sleep, mental, organic disorders ( DSM-IV-TR ; International Classification Sleep Disorders, version 2; Diseases–10). Results: Lifetime NW was 29.2% (95% confidence interval [CI] 28.5%–29.9%). In previous year, reported by 3.6% (3.3%–3.9%) sample: 1% had 2 or more episodes per month 2.6% between 1 12 year. Family history 30.5% participants. Individuals obstructive sleep apnea syndrome (odds ratio [OR] 3.9), circadian rhythm disorder (OR 3.4), insomnia 2.1), alcohol abuse/dependence 3.5), major depressive (MDD) obsessive-compulsive (OCD) using over-the-counter pills 2.5) selective serotonin reuptake inhibitor (SSRI) antidepressants 3.0) were at higher risk frequent (≥2 times/month). Conclusions: With rate 29.2%, lifetime is high. SSRIs associated an increased NW. However, these medications appear to precipitate events prior Furthermore, MDD OCD significantly greater NW, this not due use psychotropic medication. These psychiatric associations imply disturbance.